Literature DB >> 25096461

[Hepatitis B infection in children].

Vibeke Brix Christensen1, Sannie Nordly, Mette Kjær, Marianne Hørby Jørgensen.   

Abstract

Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096461

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  1 in total

Review 1.  Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases.

Authors:  Miwa Kawanaka; Ken Nishino; Hirofumi Kawamoto; Ken Haruma
Journal:  World J Gastroenterol       Date:  2021-11-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.